Stocks
Gilead Sciences, Inc.GILD
NASDAQHealthcareBiotechnology$144.99-0.15%
A U.S. biopharmaceutical company focused on antiviral therapies and specialty medicines, with leading franchises in HIV treatment and prevention. Its portfolio also includes therapies for hepatitis, oncology, and cell therapy developed through internal research and acquisitions. Investors closely wa...
Market Cap: $180.0B52W Range: $93.37 – $157.29
Congressional Interest in Gilead Sciences, Inc. (GILD)
23 members of Congress have disclosed 50 trades in Gilead Sciences, Inc. (GILD), a Healthcare company. The buy/sell breakdown shows 20 purchases versus 30 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
23
Buys
20
Sells
30
Who in Congress Is Trading GILD?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-07-12 | James M Inhofe | sell | $50K – $100K |
| 2018-05-07 | JOHN K. DELANEY | buy | $15K – $50K |